160 related articles for article (PubMed ID: 26070878)
1. Vitamin D reduces eosinophilic airway inflammation in nonatopic asthma: Are we sure?
Apte K; Salvi S
J Allergy Clin Immunol; 2015 Aug; 136(2):516-7. PubMed ID: 26070878
[No Abstract] [Full Text] [Related]
2. Vitamin D reduces eosinophilic airway inflammation in nonatopic asthma.
de Groot JC; van Roon EN; Storm H; Veeger NJ; Zwinderman AH; Hiemstra PS; Bel EH; ten Brinke A
J Allergy Clin Immunol; 2015 Mar; 135(3):670-5.e3. PubMed ID: 25617224
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D and asthma.
Columbo M
J Allergy Clin Immunol; 2015 Aug; 136(2):516. PubMed ID: 26070879
[No Abstract] [Full Text] [Related]
4. Reply: To PMID 25617224.
de Groot JC; ten Brinke A; Bel EH
J Allergy Clin Immunol; 2015 Aug; 136(2):516. PubMed ID: 26070881
[No Abstract] [Full Text] [Related]
5. Reply: To PMID 25617224.
de Groot JC; ten Brinke A; Bel EH
J Allergy Clin Immunol; 2015 Aug; 136(2):517-8. PubMed ID: 26070880
[No Abstract] [Full Text] [Related]
6. Ursodeoxycholic acid suppresses eosinophilic airway inflammation by inhibiting the function of dendritic cells through the nuclear farnesoid X receptor.
Willart MA; van Nimwegen M; Grefhorst A; Hammad H; Moons L; Hoogsteden HC; Lambrecht BN; Kleinjan A
Allergy; 2012 Dec; 67(12):1501-10. PubMed ID: 23004356
[TBL] [Abstract][Full Text] [Related]
7. Severe eosinophilic asthma treated with mepolizumab stratified by baseline eosinophil thresholds: a secondary analysis of the DREAM and MENSA studies.
Ortega HG; Yancey SW; Mayer B; Gunsoy NB; Keene ON; Bleecker ER; Brightling CE; Pavord ID
Lancet Respir Med; 2016 Jul; 4(7):549-556. PubMed ID: 27177493
[TBL] [Abstract][Full Text] [Related]
8. A new compound, 1H,8H-pyrano[3,4-c]pyran-1,8-dione, suppresses airway epithelial cell inflammatory responses in a murine model of asthma.
Lee H; Han AR; Kim Y; Choi SH; Ko E; Lee NY; Jeong JH; Kim SH; Bae H
Int J Immunopathol Pharmacol; 2009; 22(3):591-603. PubMed ID: 19822076
[TBL] [Abstract][Full Text] [Related]
9. Mepolizumab Attenuates Airway Eosinophil Numbers, but Not Their Functional Phenotype, in Asthma.
Kelly EA; Esnault S; Liu LY; Evans MD; Johansson MW; Mathur S; Mosher DF; Denlinger LC; Jarjour NN
Am J Respir Crit Care Med; 2017 Dec; 196(11):1385-1395. PubMed ID: 28862877
[TBL] [Abstract][Full Text] [Related]
10. Role of local eosinophilopoietic processes in the development of airway eosinophilia in prednisone-dependent severe asthma.
Sehmi R; Smith SG; Kjarsgaard M; Radford K; Boulet LP; Lemiere C; Prazma CM; Ortega H; Martin JG; Nair P
Clin Exp Allergy; 2016 Jun; 46(6):793-802. PubMed ID: 26685004
[TBL] [Abstract][Full Text] [Related]
11. Effects of steroid therapy on inflammatory cell subtypes in asthma.
Cowan DC; Cowan JO; Palmay R; Williamson A; Taylor DR
Thorax; 2010 May; 65(5):384-90. PubMed ID: 19996343
[TBL] [Abstract][Full Text] [Related]
12. Reslizumab for poorly controlled, eosinophilic asthma: a randomized, placebo-controlled study.
Castro M; Mathur S; Hargreave F; Boulet LP; Xie F; Young J; Wilkins HJ; Henkel T; Nair P;
Am J Respir Crit Care Med; 2011 Nov; 184(10):1125-32. PubMed ID: 21852542
[TBL] [Abstract][Full Text] [Related]
13. Cromolyn sodium suppresses eosinophilic inflammation in patients with aspirin-intolerant asthma.
Amayasu H; Nakabayashi M; Akahori K; Ishizaki Y; Shoji T; Nakagawa H; Hasegawa H; Yoshida S
Ann Allergy Asthma Immunol; 2001 Aug; 87(2):146-50. PubMed ID: 11527248
[TBL] [Abstract][Full Text] [Related]
14. Steroid naive eosinophilic asthma: anti-inflammatory effects of fluticasone and montelukast.
Jayaram L; Pizzichini E; Lemière C; Man SF; Cartier A; Hargreave FE; Pizzichini MM
Thorax; 2005 Feb; 60(2):100-5. PubMed ID: 15681495
[TBL] [Abstract][Full Text] [Related]
15. Subcutaneous prostaglandin E(2) restrains airway mast cell activity in vivo and reduces lung eosinophilia and Th(2) cytokine overproduction in house dust mite-sensitive mice.
Herrerias A; Torres R; Serra M; Marco A; Roca-Ferrer J; Picado C; de Mora F
Int Arch Allergy Immunol; 2009; 149(4):323-32. PubMed ID: 19295236
[TBL] [Abstract][Full Text] [Related]
16. The effect of omalizumab on eosinophilic inflammation of the respiratory tract in patients with allergic asthma.
Kupryś-Lipińska I; Molińska K; Kuna P
Pneumonol Alergol Pol; 2016; 84(4):232-43. PubMed ID: 27435350
[TBL] [Abstract][Full Text] [Related]
17. Treatment for severe eosinophilic asthma-consistent effect of anti-interleukin-5 antibodies?
Castro M; Bacharier LB
Lancet; 2016 Oct; 388(10056):2059-2060. PubMed ID: 27609409
[No Abstract] [Full Text] [Related]
18. Vitex rotundifolia L. prevented airway eosinophilic inflammation and airway remodeling in an ovalbumin-induced asthma mouse model.
Bae H; Kim Y; Lee E; Park S; Jung KH; Gu MJ; Hong SP; Kim J
Int Immunol; 2013 Mar; 25(3):197-205. PubMed ID: 23171813
[TBL] [Abstract][Full Text] [Related]
19. Pathological features and inhaled corticosteroid response of eosinophilic and non-eosinophilic asthma.
Berry M; Morgan A; Shaw DE; Parker D; Green R; Brightling C; Bradding P; Wardlaw AJ; Pavord ID
Thorax; 2007 Dec; 62(12):1043-9. PubMed ID: 17356056
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary Vascular Differences in Eosinophilic Asthma after 2.5 Years of Anti-IL-5Rα Treatment.
McIntosh MJ; Matheson AM; Kooner HK; Eddy RL; Serajeddini H; Yamashita C; Parraga G
Am J Respir Crit Care Med; 2023 Nov; 208(9):998-1001. PubMed ID: 37603773
[No Abstract] [Full Text] [Related]
[Next] [New Search]
